Richemont: Specialist Watchmakers Recovery Adds Another Leg To The Equity Story

Richemont shares have declined nearly 15% over the past two months, despite resilient fundamentals and continued strength at its Jewelry Maisons. Following 8% Q1 sales growth, the outlook calls for double-digit group revenue growth in Q2, led by jewelry, while improving Swiss watch indicators are expected to support a Specialist Watchmakers recovery and stronger operating leverage. Higher gold prices remain a profitability headwind, though improved watchmaker margins should partly offset the pressure.

Analysis

CFR’s setup is less about a broad luxury-demand inflection than a mix upgrade: jewelry has superior pricing power and structurally lower fashion risk, while an improving watch absorption cycle can drive disproportionate EBIT recovery because fixed retail, manufacturing and marketing costs are already embedded. The key incremental variable is whether watch demand is recovering at sell-through rather than merely through retailer replenishment; the latter would create a weaker 1-3 month earnings trade and leave inventory risk unresolved.

Higher gold costs are unlikely to be fully neutralized by price increases in the near term, but Richemont’s high-ticket jewelry positioning should preserve gross-margin dollars better than accessible-luxury peers. This creates a relative long case versus Kering (KER FP), where brand rehabilitation requires heavier marketing and product investment, and versus LVMH (MC FP), where a broader discretionary exposure provides less pure leverage to jewelry resilience. Second-order, a sustained Swiss-watch recovery would improve demand for specialist component suppliers, but it also reduces the scarcity premium supporting secondary-market prices; that is a modest risk to ultra-premium watch sentiment rather than a material Richemont earnings risk.

The contrarian issue is that the share-price decline may correctly discount a deceleration after an unusually strong comparison period, not a valuation anomaly. The thesis is falsified if jewelry growth slips below high-single digits, watch margins fail to improve despite sales growth, or gold remains elevated without sufficient pricing to protect gross margin. Near-term upside requires evidence in the next results cycle that growth is broad enough to support estimates rather than simply meet optimistic company framing.

Key Decisions for Investors

• Initiate a 1-3 month tactical long in CFR, sized modestly ahead of the next quarterly update; target a rerating toward luxury-index relative performance if jewelry growth remains double digit and Specialist Watchmakers shows sequential margin improvement. Risk/reward is attractive only with a stop on a post-results break below the recent two-month relative low.
• Express the relative thesis as long CFR / short KER FP over 3-6 months. Richemont has a cleaner route to earnings resilience through jewelry pricing and watch operating leverage, while Kering remains exposed to execution-heavy brand turnaround costs; exit if Kering demonstrates sustained acceleration in organic sales and EBIT-margin guidance.
• Do not add aggressively until management provides evidence of end-demand: monitor watch sell-through, inventory commentary and gross-margin progression. If growth is driven by wholesale restocking or gross margin contracts despite pricing, treat any post-results rally as an exit opportunity rather than confirmation.
• Hedge gold-cost risk through a small long GLD position only if gold breaks to new highs before results; the hedge protects a margin-surprise scenario, but should be removed if Richemont demonstrates price realization sufficient to stabilize jewelry gross margin.